Page 241 - WSAVA2018
P. 241

WSV18-0181
HEMATOLOGY AND ENDOCRINOLOGY (SIMULTANEOUS TRANSLATION INTO MANDARIN CHINESE)
UPDATE ON IMMUNE-MEDIATED HEMOLYTIC ANEMIA IN DOGS
U. Giger1
1School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA
Immune-mediated hemolytic anemia (IMHA) is a common hematological disorder in dogs, may be primary (idiopathic, autoimmune) or occur secondarily to underlying diseases and is often associated with life-threatening complications. The diagnostic approach and its management with immunosuppression and transfusion support will be discussed with emphasis on evidence and controversies.
Introduction
Immune-mediated hemolytic anemia (IMHA) is one
of the most common and serious hemolytic anemias
in dogs, but occurs rarely in other animal species. In IMHA an immune response, including anti-erythrocytic antibodies, complement and macrophages, targets directly or indirectly erythrocytes and a hemolytic anemia ensues. There are many triggers for IMHA such as infections, drugs and other agents, and cancer leading to secondary IMHA, but in many dogs no cause is identified (so-called idiopathic, autoimmune or primary IMHA) or
a genetic predisposition has been proposed (Cocker spaniels). Furthermore, alloimmune hemolytic anemias, such as hemolytic transfusion reactions, both acute
and delayed, and neonatal isoerythrolysis (only litters from transfused bitches), are caused by specific anti- erythrocytic alloantibodies. In contrast to other species, dogs with IMHA also develop an often overwhelming inflammatory response resulting in thrombosis and necrosis of various organs. And while the anemia can
be corrected with transfusions, these complications in dogs are causing severe morbidity and mortality despite aggressive immunosuppression and antithrombotic interventions.
Immune Destruction of Erythrocytes
Regardless of the underlying cause, IMHA results
from a breakdown in immune self-tolerance or from a deficit in the control mechanism that regulates B and T lymphocyte activity as well as macrophage reactivity. Immune destruction of erythrocytes is initiated by
the binding of IgG or IgM antibodies to the surface
of erythrocytes. Under most clinical circumstances, immune destruction is an extravascular process that depends on recognition of erythrocytes opsonized with IgG, IgM and/or complement by specific receptors on reticuloendothelial cells. Macrophages with engulfed
erythrocytes may be noted on cytological examination of blood and tissue aspirates as erythrophagocytosis, but this is not definitive proof of an immune-mediated process. Antibody-coated erythrocytes may also be lysed by complement fixation and the membrane attack complex, which is clinically noted as intravascular hemolysis.
A diagnosis of IMHA must demonstrate accelerated immune destruction of erythrocytes. Evidence of a hemolytic anemia is suggested clinically by icterus
and a regenerative anemia with hyperbilirubinuria,
and hemoglobinemia and hemoglobinuria refers to an intravascular process. However, the erythroid response in the bone marrow may be blunted by the immune and inflammatory process or the underlying disease thereby leading to non-regenerative anemias. Besides documenting a hemolytic anemia, one or more of the following three hallmarks must be present to support
a diagnosis of immune-mediated hemolysis: persistent autoagglutination, marked spherocytosis and a positive direct Coombs’ test result. As in human medicine,
the Coombs’ test should be considered the best
test to definitively diagnose IMHA, although marked spherocytosis and persistent/true autoagglutination (after 3x washing of EDTA blood with saline) are other important parameters indicating immune-destruction of erythrocytes.
Autoagglutination
Anti-erythrocytic IgM and in large quantities IgG antibodies may cause direct erythrocyte autoagglutination. The autoagglutination may be seen by naked eye in an
EDTA tube or on a glass slide or may become apparent
as small clumps of erythrocytes on blood smears. For
yet unexplained reasons, canine erythrocytes have a tendency to unspecifically agglutinate in the presence of plasma and colder temperatures as well as possibly with excessive EDTA anticoagulant. Mixing blood with one drop of saline may break up rouleaux formation but not other forms of unspecific red cell agglutination. It is, therefore, important to determine whether the agglutination persists after “saline washing”, which has been coined persistent or true autoagglutination. This is accomplished by adding physiologic saline to the tube containing a small amount of EDTA-anticoagulated blood, mixing, centrifuging and removing the supernatant including the plasma and repeating this saline washing 3 times. True or persistent autoagglutination is indicative of an immune process,
but precludes the performance of Coombs’ test or
blood typing and crossmatching procedures which are based upon an agglutination reaction as result. Those based upon chromatographic techniques do not seem
to be affected by autoagglutination as free red cells can move along the strip. If the agglutination breaks up after washing, the Coombs’ test is expected to be positive, if it is a case of IMHA. There is no evidence for washing away red cell bound antibodies in dogs.
Your Singapore, the Tropical Garden City
          239
            































































   239   240   241   242   243